Vitamin D and its' role in Parkinson's disease patients with SARS-CoV-2 infection. A review article
A novel coronavirus reportedly called 2019-nCoV started to spread around the world at the end of 2019. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was later renamed after links with SARS were observed. Multiple studies have reported possible connections between the COVID-19 virus an...
Guardado en:
Autores principales: | , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://doaj.org/article/d3d968c70d2144b9906c5600b62431fb |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:d3d968c70d2144b9906c5600b62431fb |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:d3d968c70d2144b9906c5600b62431fb2021-12-02T05:01:44ZVitamin D and its' role in Parkinson's disease patients with SARS-CoV-2 infection. A review article2214-751910.1016/j.inat.2021.101441https://doaj.org/article/d3d968c70d2144b9906c5600b62431fb2022-03-01T00:00:00Zhttp://www.sciencedirect.com/science/article/pii/S2214751921003534https://doaj.org/toc/2214-7519A novel coronavirus reportedly called 2019-nCoV started to spread around the world at the end of 2019. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was later renamed after links with SARS were observed. Multiple studies have reported possible connections between the COVID-19 virus and neurodegenerative diseases, including Parkinson's disease. Theories support that vitamin D deficiency plays a part in the pathogenicity of Parkinson's disease or the credibility of the associated dopamine system. Administration of vitamin D3 was shown to significantly enhance the motor and non-motor manifestations of Parkinson's disease and enhance the quality of life. Also, multiple recent reviews have shown specific ways in which vitamin D reduces the risk of pathogenic infections. Recent studies supported the potential role of vitamin D in reducing the risk of COVID-19 infections and mortality. On the immunological level, immune response regulation remains one of the well-recognized actions of vitamin D. Vitamin D deficiency has been linked to complications in patients with SARS-CoV-2 infection and Parkinson's disease. Whereas more studies are required, Vitamin D supplementation with a moderate and well-calculated dosage of vitamin D3 in patients with Parkinson's disease can help minimize the risk and burden of COVID-19 complications.Ahmed Y AzzamSherief GhozyMohammed A AzabElsevierarticleCOVID-19Parkinson's diseaseSARS-CoV-2Vitamin DSurgeryRD1-811Neurology. Diseases of the nervous systemRC346-429ENInterdisciplinary Neurosurgery, Vol 27, Iss , Pp 101441- (2022) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
COVID-19 Parkinson's disease SARS-CoV-2 Vitamin D Surgery RD1-811 Neurology. Diseases of the nervous system RC346-429 |
spellingShingle |
COVID-19 Parkinson's disease SARS-CoV-2 Vitamin D Surgery RD1-811 Neurology. Diseases of the nervous system RC346-429 Ahmed Y Azzam Sherief Ghozy Mohammed A Azab Vitamin D and its' role in Parkinson's disease patients with SARS-CoV-2 infection. A review article |
description |
A novel coronavirus reportedly called 2019-nCoV started to spread around the world at the end of 2019. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was later renamed after links with SARS were observed. Multiple studies have reported possible connections between the COVID-19 virus and neurodegenerative diseases, including Parkinson's disease. Theories support that vitamin D deficiency plays a part in the pathogenicity of Parkinson's disease or the credibility of the associated dopamine system. Administration of vitamin D3 was shown to significantly enhance the motor and non-motor manifestations of Parkinson's disease and enhance the quality of life. Also, multiple recent reviews have shown specific ways in which vitamin D reduces the risk of pathogenic infections. Recent studies supported the potential role of vitamin D in reducing the risk of COVID-19 infections and mortality. On the immunological level, immune response regulation remains one of the well-recognized actions of vitamin D. Vitamin D deficiency has been linked to complications in patients with SARS-CoV-2 infection and Parkinson's disease. Whereas more studies are required, Vitamin D supplementation with a moderate and well-calculated dosage of vitamin D3 in patients with Parkinson's disease can help minimize the risk and burden of COVID-19 complications. |
format |
article |
author |
Ahmed Y Azzam Sherief Ghozy Mohammed A Azab |
author_facet |
Ahmed Y Azzam Sherief Ghozy Mohammed A Azab |
author_sort |
Ahmed Y Azzam |
title |
Vitamin D and its' role in Parkinson's disease patients with SARS-CoV-2 infection. A review article |
title_short |
Vitamin D and its' role in Parkinson's disease patients with SARS-CoV-2 infection. A review article |
title_full |
Vitamin D and its' role in Parkinson's disease patients with SARS-CoV-2 infection. A review article |
title_fullStr |
Vitamin D and its' role in Parkinson's disease patients with SARS-CoV-2 infection. A review article |
title_full_unstemmed |
Vitamin D and its' role in Parkinson's disease patients with SARS-CoV-2 infection. A review article |
title_sort |
vitamin d and its' role in parkinson's disease patients with sars-cov-2 infection. a review article |
publisher |
Elsevier |
publishDate |
2022 |
url |
https://doaj.org/article/d3d968c70d2144b9906c5600b62431fb |
work_keys_str_mv |
AT ahmedyazzam vitamindanditsroleinparkinsonsdiseasepatientswithsarscov2infectionareviewarticle AT sheriefghozy vitamindanditsroleinparkinsonsdiseasepatientswithsarscov2infectionareviewarticle AT mohammedaazab vitamindanditsroleinparkinsonsdiseasepatientswithsarscov2infectionareviewarticle |
_version_ |
1718400797880877056 |